"This is the thing," Fox said of new research. "This is the big reward. This is the big trophy."
Courtesy Mark Seliger A Parkinson's 'game changer,' backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments Research funded by the Michael J. Fox Foundation for Parkinson's Research has resulted in the clearest evidence yet that the presence of a particular misfolded protein can be used to determine if people have Parkinson's. It is an advance that may soon be used to develop better diagnostics and rapidly accelerate the search for treatments for the disease. Read more. By Matthew Herper |
|
Kristoffer Tripplaar/SIPA via AP Exclusive: FDA staff leaned toward rejecting Sarepta gene therapy before top official intervened Reviewers at the FDA were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to step in earlier this year. Read more. By Adam Feuerstein and Jason Mast Courtesy Ole Frøbert Scientists, going on a bear hunt, find a potential way to treat deadly blood clots Cardiologist Manuela Thienel believes hibernating bears may hold an answer to an ailment that kills up to 100,000 Americans every year. When humans are rendered immobile for weeks or months, they are at high risk for a potentially fatal blood clot called venous thromboembolism. Yet every year brown bears curl up for four to seven months and suffer no blood-congealing consequences. Read more. By Jason Mast More great reads from STAT this week |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments